Ingrid MASSE

Dr. Ingrid MASSE

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
WCWen Cai
Wen Cai
JRJuliette Rambaud
Juliette Rambaud
MTMichèle Teboul
Michèle Teboul
IMIngrid MASSE
Ingrid MASSE
GBGerard Benoit
Gerard Benoit
IPIngemar Pongratz
Ingemar Pongratz
Circadian regulation of gene expression plays a major role in health and disease. The precise role of the circadian system remains to be clarified, but it is known that circadian proteins generate physiological rhythms in organisms by regulating clock-controlled target genes. The estrogen receptor beta (ERbeta) is, together with ERalpha, a member of the nuclear receptor superfamily and a key mediator of estrogen action. Interestingly, recent studies show that disturbed circadian rhythmicity in humans can increase the risk of reproductive malfunctions, suggesting a link between the circadian system and ER-mediated transcription pathways. Here, we identify a novel level of regulation of estrogen signaling where ERbeta, but not ERalpha, is controlled by circadian clock proteins. We show that ERbeta mRNA levels fluctuate in different peripheral tissues following a robust circadian pattern, with a peak at the light-dark transition, which is maintained under free-running conditions. Interestingly, this oscillation is abolished in clock-deficient BMAL1 knockout mice. Circadian control of ERbeta expression is exerted through a conserved E-box element in the ERbeta promoter region that recruits circadian regulatory factors. Furthermore, using small interfering RNA-mediated knockdown assays, we show that the expression levels of the circadian regulatory factors directly influence estrogen signaling by regulating the intracellular levels of endogenous ERbeta.

1 February 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NWNing Wu
Ning Wu
JRJérome Rollin
Jérome Rollin
IMIngrid MASSE
Ingrid MASSE
JLJérôme Lamartine
Jérôme Lamartine
XGXavier Gidrol
Xavier Gidrol
Although p63 and MYC are important in the control of epidermal homeostasis, the underlying molecular mechanisms governing keratinocyte proliferation or differentiation downstream of these two genes are not completely understood. By analyzing the transcriptional changes and phenotypic consequences of the loss of either p63 or MYC in human developmentally mature keratinocytes, we have characterized the networks acting downstream of these two genes to control epidermal homeostasis. We show that p63 is required to maintain growth and to commit to differentiation by two distinct mechanisms. Knockdown of p63 led to down-regulation of MYC via the Wnt/β-catenin and Notch signaling pathways and in turn reduced keratinocyte proliferation. We demonstrate that a p63-controlled keratinocyte cell fate network is essential to induce the onset of keratinocyte differentiation. This network contains several secreted proteins involved in cell migration/adhesion, including fibronectin 1 (FN1), interleukin-1β (IL1B), cysteine-rich protein 61 (CYR61), and jagged-1 (JAG1), that act downstream of p63 as key effectors to trigger differentiation. Our results characterized for the first time a connection between p63 and MYC and a cell adhesion-related network that controls differentiation. Furthermore, we show that the balance between the MYC-controlled cell cycle progression network and the p63-controlled cell adhesion-related network could dictate skin cell fate.

13 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
GRGael Runel
Gael Runel
NLNoémie Lopez-Ramirez
Noémie Lopez-Ramirez
JCJULIEN CHLASTA
JULIEN CHLASTA
IMIngrid MASSE
Ingrid MASSE
Since the crucial role of the microenvironment has been highlighted, many studies have been focused on the role of biomechanics in cancer cell growth and the invasion of the surrounding environment. Despite the search in recent years for molecular biomarkers to try to classify and stratify cancers, much effort needs to be made to take account of morphological and nanomechanical parameters that could provide supplementary information concerning tissue complexity adaptation during cancer development. The biomechanical properties of cancer cells and their surrounding extracellular matrix have actually been proposed as promising biomarkers for cancer diagnosis and prognosis. The present review first describes the main methods used to study the mechanical properties of cancer cells. Then, we address the nanomechanical description of cultured cancer cells and the crucial role of the cytoskeleton for biomechanics linked with cell morphology. Finally, we depict how studying interaction of tumor cells with their surrounding microenvironment is crucial to integrating biomechanical properties in our understanding of tumor growth and local invasion.

8 October 2010 in Aging Cell
Verified
Journal Article
Open access
PDF file
LMLaurent Mouchiroud
Laurent Mouchiroud
LMLaurent Molin
Laurent Molin
PKPrasad Kasturi
Prasad Kasturi
MTMohamed N. Triba
Mohamed N. Triba
MDMarc Emmanuel Dumas
Marc Emmanuel Dumas
FSFlorence Solari
Florence Solari
Summary: Dietary restriction (DR) is the most universal intervention known to extend animal lifespan. DR also prevents tumor development in mammals, and this effect requires the tumor suppressor PTEN. However, the metabolic and cellular processes that underly the beneficial effects of DR are poorly understood. We identified slcf‐1 in an RNAi screen for genes that extend Caenorhabditis elegans lifespan in a PTEN/daf‐18‐dependent manner. We showed that slcf‐1 mutation, which increases average lifespan by 40%, mimics DR in worms fed ad libitum. An NMR‐based metabolomic characterization of slcf‐1 mutants revealed lower lipid levels compared to wild‐type animals, as expected for dietary‐restricted animals, but also higher pyruvate content. Epistasis experiments and metabolic measurements support a model in which the long lifespan of slcf‐1 mutants relies on increased mitochondrial pyruvate metabolism coupled to an adaptive response to oxidative stress. This response requires DAF‐18/PTEN and the previously identified DR effectors PHA‐4/FOXA, HSF‐1/HSF1, SIR‐2.1/SIRT‐1, and AMPK/AAK‐2. Overall, our data show that pyruvate homeostasis plays a central role in lifespan control in C. elegans and that the beneficial effects of DR results from a hormetic mechanism involving the mitochondria. Analysis of the SLCF‐1 protein sequence predicts that slcf‐1 encodes a plasma membrane transporter belonging to the conserved monocarboxylate transporter family. These findings suggest that inhibition of this transporter homolog in mammals might also promote a DR response.

6 January 2005 in Oncogene
Verified
Journal Article
Closed access
FSFlorence Solari
Florence Solari
ABAngélique Bourbon-Piffaut
Angélique Bourbon-Piffaut
IMIngrid MASSE
Ingrid MASSE
BPBernard Payrastre
Bernard Payrastre
ACAndrew Chan
Andrew Chan
MBMarc Billaud
Marc Billaud

12 November 2019 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
AHAurelie Houlier
Aurelie Houlier
DPDaniel Pissaloux
Daniel Pissaloux
IMIngrid MASSE
Ingrid MASSE
FTFranck Tirode
Franck Tirode
MKMarie Karanian
Marie Karanian
AFArnaud De La Fouchardière
Arnaud De La Fouchardière